NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $77,000 | -2.5% | 109,135 | 0.0% | 0.03% | -6.1% |
| Q3 2019 | $79,000 | -7.1% | 109,135 | 0.0% | 0.03% | -8.3% |
| Q2 2019 | $85,000 | -36.6% | 109,135 | 0.0% | 0.04% | -32.1% |
| Q1 2019 | $134,000 | +45.7% | 109,135 | 0.0% | 0.05% | +23.3% |
| Q4 2018 | $92,000 | -71.5% | 109,135 | -0.0% | 0.04% | -59.0% |
| Q3 2018 | $323,000 | -19.7% | 109,184 | 0.0% | 0.10% | -30.5% |
| Q2 2018 | $402,000 | +5.2% | 109,184 | 0.0% | 0.15% | -3.8% |
| Q1 2018 | $382,000 | +12.0% | 109,184 | 0.0% | 0.16% | +15.4% |
| Q4 2017 | $341,000 | -55.6% | 109,184 | 0.0% | 0.14% | -58.5% |
| Q3 2017 | $768,000 | -23.8% | 109,184 | 0.0% | 0.33% | -22.1% |
| Q2 2017 | $1,008,000 | -14.1% | 109,184 | 0.0% | 0.42% | -25.4% |
| Q1 2017 | $1,173,000 | +27.6% | 109,184 | 0.0% | 0.56% | +22.1% |
| Q4 2016 | $919,000 | – | 109,184 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 1,800,000 | $1,404,000 | 2.63% |
| Stonepine Capital Management, LLC | 491,096 | $383,000 | 0.26% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 918,342 | $716,000 | 0.05% |
| KNOTT DAVID M | 109,135 | $85,000 | 0.04% |
| EdgePoint Investment Group Inc. | 2,831,555 | $2,209,000 | 0.02% |
| Yakira Capital Management, Inc. | 36,428 | $28,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 46,000 | $36,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 85,409 | $66,000 | 0.00% |
| FARMERS & MERCHANTS INVESTMENTS INC | 191 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 37,717 | $29,000 | 0.00% |